Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age
Open Access
- 8 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 13, 631827
Abstract
As the main immune cells of the central nervous system (CNS), microglia regulates normal development, homeostasis and general brain physiology. These functions put microglia at the forefront of CNS repair and recovery. Uncontrolled activation of microglia is related to the course of neurodegenerative diseases such as Alzheimer’s disease. It is clear that the classic pathologies of amyloid β (Aβ) and Tau are usually accompanied by the activation of microglia, and the activation of microglia also serves as an early event in the pathogenesis of AD. Therefore, during the occurrence and development of AD, the key susceptibility factors for AD—apolipoprotein E (APOE) genotype, sex and age—may further interact with microglia to exacerbate neurodegeneration. In this review, we discuss the role of microglia in the progression of AD related to the three risk factors for AD: APOE genotype, sex and aging. APOE-expressing microglia accumulates around Aβ plaques, and the presence of APOE4 may disrupt the phagocytosis of Aβ aggregates and aggravate neurodegeneration in Tau disease models. In addition, females have a high incidence of AD, and normal female microglia and estrogen have protective effects under normal conditions. However, under the influence of AD, female microglia seem to lose their protective effect and instead accelerate the course of AD. Aging, another major risk factor, may increase the sensitivity of microglia, leading to the exacerbation of microglial dysfunction in elderly AD. Obviously, in the role of microglia in AD, the three main risk factors of APOE, sex, and aging are not independent and have synergistic effects that contribute to the risk of AD. Moreover, new microglia can replace dysfunctional microglia after microglial depletion, which is a new promising strategy for AD treatment.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 151 references indexed in Scilit:
- Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like PathologyPLOS ONE, 2013
- Origin and differentiation of microgliaFrontiers in Cellular Neuroscience, 2013
- The brain’s best friend: microglial neurotoxicity revisitedFrontiers in Cellular Neuroscience, 2013
- APOE genotype alters glial activation and loss of synaptic markers in miceGlia, 2012
- Sex differences in microglial colonization of the developing rat brainJournal of Neurochemistry, 2011
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomesMolecular Biology of the Cell, 2011
- Apolipoprotein E isoform‐dependent microglia migrationThe FASEB Journal, 2011
- APOE genotype-specific differences in the innate immune responseNeurobiology of Aging, 2009
- Understanding the Association of Apolipoprotein E4 with Alzheimer Disease: Clues from Its StructureJournal of Biological Chemistry, 2009